2 Attractive Biotech Stocks, With Good Entry Points

In this article, I will focus on two biotechnology drug companies that has very huge potential for growth, with nice entry points.

The Company's other product, LODOTRA (NP-01) is a proprietary programmed-release formulation of low-dose prednisone and has received regulatory approval for the treatment of moderate to severe active rheumatoid arthritis (RA) when accompanied by morning stiffness in Europe where it is promoted by Mundipharma. CLICK HERE>> TO READ MORE